Article
Functional Epigenomics Identifies Genes Frequently Silenced in Prostate Cancer
15 May 2005
Abstract excerpt
In many cases, silencing of gene expression by CpG methylation is causally involved in carcinogenesis. Furthermore, cancer-specific CpG methylation may serve as a tumor marker. In order to identify candidate genes for inactivation by CpG methylation in prostate cancer, the prostate cancer cell lines LNCaP, PC3, and Du-145 were treated with 5-aza-2' deoxycytidine and trichostatin A, which leads to reversion of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
